Boston Life Sciences, Inc. Announces Webcast of 2006 Annual Meeting
14 December 2006 - 5:32AM
PR Newswire (US)
HOPKINTON, Mass., Dec. 13 /PRNewswire-FirstCall/ -- Boston Life
Sciences, Inc. (NASDAQ:BLSI) today announced that the Company will
webcast the corporate presentation portion of its Annual Meeting of
Stockholders. The meeting is being held on Thursday, December 14,
2006 at 1:00p.m. EST at the offices of Wilmer Cutler Pickering Hale
& Dorr, 60 State Street, Boston, MA. The webcast is expected to
begin at approximately 1:15p.m. EST and will be available on the
Investor Relations section of the Company's website at
http://www.bostonlifesciences.com/. The event will be archived and
available for replay through December 14, 2007. About Boston Life
Sciences, Inc. Boston Life Sciences, Inc. (BLSI) is engaged in the
research and clinical development of diagnostic and therapeutic
products for central nervous system (CNS) disorders. ALTROPANE(R)
molecular imaging agent is in Phase III clinical trials for the
diagnosis of Parkinsonian Syndrome (PS) and Phase II clinical
trials for the diagnosis of Attention Deficit Hyperactivity
Disorder (ADHD). The Company's research and pre-clinical CNS
programs include Inosine for the treatment of stroke, a DAT blocker
for the treatment of Parkinson's disease and a second generation
technetium-based molecular imaging agent for PS and ADHD. BLSI's
current research collaborations include Harvard Medical School and
Children's Hospital Boston. Contact: Meredith Patin -- 508-497-2360
ext 239 Boston Life Sciences, Inc. DATASOURCE: Boston Life
Sciences, Inc. CONTACT: Meredith Patin of Boston Life Sciences,
Inc., +1-508-497-2360, ext. 239, Web site:
http://www.bostonlifesciences.com/
Copyright
Boston Life Sciences (NASDAQ:BLSI)
Historical Stock Chart
From May 2024 to Jun 2024
Boston Life Sciences (NASDAQ:BLSI)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Boston Life Sciences (MM) (NASDAQ): 0 recent articles
More Boston Life Sciences (MM) News Articles